6.10
-0.34 (-5.28%)
| Previous Close | 6.44 |
| Open | 6.39 |
| Volume | 402,427 |
| Avg. Volume (3M) | 229,867 |
| Market Cap | 165,605,744 |
| Price / Sales | 0.490 |
| Price / Book | 0.930 |
| 52 Weeks Range | |
| Earnings Date | 6 May 2026 |
| Profit Margin | -8.08% |
| Operating Margin (TTM) | -9.31% |
| Diluted EPS (TTM) | -1.15 |
| Quarterly Revenue Growth (YOY) | 5.50% |
| Total Debt/Equity (MRQ) | 9.70% |
| Current Ratio (MRQ) | 3.07 |
| Operating Cash Flow (TTM) | -6.13 M |
| Levered Free Cash Flow (TTM) | -16.59 M |
| Return on Assets (TTM) | -6.19% |
| Return on Equity (TTM) | -14.10% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Mixed | Bearish |
| Medical Devices (Global) | Mixed | Bearish | |
| Stock | Inogen, Inc | Mixed | Bullish |
AIStockmoo Score
| Analyst Consensus | NA |
| Insider Activity | 3.0 |
| Price Volatility | 0.5 |
| Technical Moving Averages | -2.5 |
| Technical Oscillators | -2.5 |
| Average | -0.38 |
|
Inogen Inc is a medical technology business that focuses on respiratory health. It develops, manufactures, and markets respiratory health products, including portable oxygen concentrators, or POCs, used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions and the Simeox product for airway clearance treatment. In addition, it has started distributing the Inogen Voxi 5 stationary oxygen concentrator as well as the Aurora continuous positive airway pressure, or CPAP, masks in the United States. The company derives revenues from customers through the development, manufacturing, marketing, sales, and rental of respiratory products. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Value |
| % Held by Insiders | 12.00% |
| % Held by Institutions | 72.53% |
No data within this time range.
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| BOEHNLEIN GLENN S | 6.41 | - | 28,081 | 179,999 |
| JAMALI VAFA | 6.41 | - | 28,081 | 179,999 |
| KING KEVIN M | 6.41 | - | 28,081 | 179,999 |
| LADONE MARY KAY | 6.41 | - | 28,081 | 179,999 |
| MORA ELIZABETH | 6.41 | - | 28,081 | 179,999 |
| RIDER HEATHER D. | 6.41 | - | 28,081 | 179,999 |
| SAHNEY MIRA KIRTI | 6.41 | - | 28,081 | 179,999 |
| Aggregate Net Quantity | 196,567 | |||
| Aggregate Net Value ($) | 1,259,994 | |||
| Aggregate Avg. Buy ($) | 6.41 | |||
| Aggregate Avg. Sell ($) | - | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| KING KEVIN M | Director | 05 Jun 2026 | Acquired (+) | 28,081 | 6.41 | 179,999 |
| LADONE MARY KAY | Director | 05 Jun 2026 | Acquired (+) | 28,081 | 6.41 | 179,999 |
| MORA ELIZABETH | Director | 05 Jun 2026 | Acquired (+) | 28,081 | 6.41 | 179,999 |
| RIDER HEATHER D. | Director | 05 Jun 2026 | Acquired (+) | 28,081 | 6.41 | 179,999 |
| BOEHNLEIN GLENN S | Director | 05 Jun 2026 | Acquired (+) | 28,081 | 6.41 | 179,999 |
| JAMALI VAFA | Director | 05 Jun 2026 | Acquired (+) | 28,081 | 6.41 | 179,999 |
| SAHNEY MIRA KIRTI | Director | 05 Jun 2026 | Acquired (+) | 28,081 | 6.41 | 179,999 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |